(+)-13,20-Epoxy-1�,6a,11�,12a,14,15�,21-heptahydroxypicrasa-3-ene-2,16-dione(CAS: 95258-13-2)

Yadanziolide B (CAS: 95258-13-2) falls under the Chemicals of Very High Concern (SVHC) list under the REACH regulation. It may require a safety data sheet (SDS) and registration with ECHA. In the US, the FDA may regulate it under the Toxic Substances Control Act if it is used in consumer products. Additionally, it should comply with local and national hazardous waste regulations.

Yadanziolide B (CAS: 95258-13-2) can often be synthesized using similar structural analogs such as diterpenoids. Common alternatives include (−)-taxadiene or (−)-taxol, which can serve as precursors or substitutes. Other routes might involve using isomers or structurally related compounds depending on the specific application.

Research on Yadanziolide B (CAS: 95258-13-2) is mainly focused on its potential biological activities, particularly in anti-inflammatory and anti-cancer applications. Market trends suggest increasing interest in natural product derivatives for medicinal use. However, due to its complexity, large-scale production and commercialization remain challenging.

Waste containing Yadanziolide B (CAS: 95258-13-2) should be collected in appropriate containers and stored in a well-ventilated area. Incineration is a common method for disposal, but professional waste disposal services should be used to ensure compliance with environmental protection regulations. It is crucial to follow local hazardous waste management guidelines to prevent environmental contamination.